THE USE OF PLASMA MELATONIN LEVELS AND LIGHT IN THE ASSESSMENT AND TREATMENT OF CHRONOBIOLOGIC SLEEP AND MOOD DISORDERS

CORRECTIONS AND ADDITIONS TO THE HISTORY OF LIGHT THERAPY AND SEASONAL AFFECTIVE-DISORDER

Circadian-rhythm sleep disorders in persons who are totally blind

Circadian rhythm sleep disorders: lessons from the blind

THE IMPORTANCE OF MELATONIN AND TUMOR-MARKERS IN PINEAL TUMORS

The effect of circadian phase on sleep efficiency in blind people with free-running rhythms

Relative coordination to unknown weak Zeitgebers influences lowest entraining dose of exogenous melatonin

SUNLIGHT AND ARTIFICIAL-LIGHT HAVE DIFFERENT EFFECTS ON MELATONIN SECRETION IN HUMANS

DISAPPEARANCE OF PLASMA MELATONIN AFTER SURGICAL REMOVAL OF A NEOPLASTIC PINEAL-GLAND

EVIDENCE FOR A PHASE RESPONSE CURVE AND A CLOCK-GATE MODEL FOR THE REGULATION OF THE TIMING OF HUMAN MELATONIN PRODUCTION

MELATONIN - A LINK BETWEEN THE ENVIRONMENT AND BEHAVIOR - COMMENTARY

Melatonin and sleep in the elderly

Bright morning Light reduces depressive symptoms in seasonal affective disorder

Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2nd edition.

The "sweet spot" for the plasma dim light melatonin onset for winter depressives treated with low-dose daytime melantonin: Support for the phase shift hypothesis (PSH)

In winter depression (SAD), the sweet spot for the 10 pg/ml plasma dim light melatonin onset (DLMO) is six hours before mid-sleep

Developmental aspects of entrained vs. free-running circadian rhythms

Women have a longer phase angle of entrainment than men

Plasminogen activator inhibitor-I has a circadian rhythm in blind individuals